Cadent Therapeutics

About:

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

Website: http://www.cadenttx.com

Twitter/X: CadentTx

Top Investors: Qiming Venture Partners, Slater Technology Fund, Atlas Venture, Access Industries, Cowen Healthcare Investments

Description:

Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders. It was founded in 2010 and headquartered in Cambridge, Massachusetts.

Total Funding Amount:

$66.7M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)cadenttx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2020-04-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai